Clinical Trials on Secondary Progressive MS
Total 2769 results
-
SanofiCompletedProgressive Multiple SclerosisGermany
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedPrimary Progressive Multiple SclerosisUnited States, Canada, Germany, Italy, Netherlands, Poland, Russian Federation, Spain, Ukraine, United Kingdom
-
Indiana UniversityUniversity of Alabama at Birmingham; University of OttawaCompletedProgressive Multiple SclerosisUnited States
-
Nantes University HospitalCompletedProgressive Multiple SclerosisFrance
-
University of CalgaryCompletedMultiple Sclerosis, Primary ProgressiveCanada
-
National Institute of Allergy and Infectious Diseases...CompletedMultiple Sclerosis | Primary Progressive Multiple SclerosisUnited States
-
Genzyme, a Sanofi CompanyCompletedProgressive Multiple SclerosisSpain
-
Duke UniversityUnited States Department of Defense; Prostate Cancer Foundation; Janssen Diagnostics...CompletedMetastatic Progressive Castration-resistant Prostate Cancer | Metastatic Progressive Breast CancerUnited States
-
North Bristol NHS TrustUniversity of Nottingham; Medical Research Council; University of Bristol; Bristol... and other collaboratorsUnknownProgressive Multiple SclerosisUnited Kingdom
-
Universitätsklinikum Hamburg-EppendorfDeutsche Multiple Sklerose Gesellschaft HamburgUnknown
-
MedDay Pharmaceuticals SAUnknown
-
University of GlasgowNHS Ayrshire and Arran; AKMCompletedProgressive Multiple SclerosisUnited Kingdom
-
Genzyme, a Sanofi CompanyCompletedProgressive Multiple SclerosisGermany
-
Rigshospitalet, DenmarkCompletedProgressive Multiple SclerosisDenmark
-
Sudhalkar Eye HospitalCompletedProgression | Complications of Treatment
-
Chinese University of Hong KongCompletedHyperparathyroidism | Arterial StiffnessHong Kong
-
Universitaire Ziekenhuizen KU LeuvenCompletedHematologic Diseases | Secondary Immune DeficiencyBelgium
-
St. Franziskus HospitalUniversity of Erlangen-Nürnberg Medical SchoolCompletedUveitis | Secondary GlaucomaGermany
-
AmgenCompletedSecondary HyperparathyroidismChina
-
Ain Shams UniversityCompleted
-
Genzyme, a Sanofi CompanyCompletedSecondary HyperparathyroidismUnited States
-
Charite University, Berlin, GermanyRecruitingMultiple Sclerosis (MS) | Clinically Isolated Syndrome (CIS)Germany
-
Smith & Nephew Orthopaedics AGCompletedPrimary and Secondary Omarthrosis
-
Novartis PharmaceuticalsRecruitingMultiple Sclerosis (MS)United States, Belgium, Taiwan, Italy, Germany, Canada, Estonia, Mexico, Croatia, Slovakia, Turkey, India, Spain, Argentina, France, Israel, Australia, Austria, Serbia, Brazil, Guatemala, Latvia, Poland, Portugal, Russian Federation, Romania and more
-
The Hospital for Sick ChildrenUnity Health Toronto; Queen's University; Multiple Sclerosis Society of Canada; Stem Cell Network and other collaboratorsRecruitingMultiple Sclerosis (MS)Canada
-
Hoffmann-La RocheActive, not recruitingMultiple Sclerosis (MS)United States
-
Bristol-Myers SquibbCompleted
-
AbbVieCompletedMultiple Sclerosis (MS)United States, Canada
-
University of Texas Southwestern Medical CenterGenzyme, a Sanofi CompanyCompletedMultiple Sclerosis (MS)United States
-
Hadassah Medical OrganizationWithdrawnMS Patient With Relpasing Remitting AttacksIsrael
-
AmgenCompletedChronic Kidney Disease | Secondary HyperparathyroidismKorea, Republic of, Taiwan, Hong Kong, China, India, Malaysia
-
AmgenCompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Hyperparathyroidism, SecondaryUnited States, Germany, United Kingdom
-
Benha UniversityNew Jeddah Clinic HospitalCompletedDiabetic Nephropathies | Secondary Hyperparathyroidism
-
The University of Hong KongAbbVieUnknownSecondary Hyperparathyroidism | Endstage Renal DiseaseHong Kong
-
AbbottCompletedHemodialysis | Chronic Kidney Disease | Secondary HyperparathyroidismUnited States, Czech Republic, Denmark, Germany, Greece, Italy, Netherlands, Portugal, Russian Federation, Spain, Sweden, United Kingdom
-
ENRICO VERRINAUnknownSecondary HyperparathyroidismItaly
-
AbbottCompletedHemodialysis | Secondary HyperparathyroidismJapan
-
First Affiliated Hospital of Chengdu Medical CollegeRecruitingPrimary Aldosteronism | Resistant Hypertension | Secondary Hypertension | Secondary Hypertension to Endocrine DisordersChina
-
Chengdu Suncadia Medicine Co., Ltd.Not yet recruiting
-
AbbVie (prior sponsor, Abbott)CompletedEvaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)Chronic Kidney Disease | Secondary HyperparathyroidismBulgaria, Czech Republic, Romania
-
AmgenCompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Kidney Disease
-
The University of Hong KongResearch Grants Council, Hong KongRecruitingFear of Cancer Progression | Metacognition-based Intervention | Supportive-expressive Based Intervention | Psychooncology | Advanced or Metastatic CancerHong Kong
-
Infectious Diseases Research Collaboration, UgandaMakerere UniversityRecruitingHIV Disease ProgressionUganda
-
Laboratorios Sophia S.A de C.V.Not yet recruiting
-
Beijing Airdoc Technology Co., Ltd.Eye & ENT Hospital of Fudan UniversityRecruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityThe Second People's Hospital of Foshan; Tianjin Medical University Eye CenterRecruitingEye Diseases | Refractive Errors | Myopia, ProgressiveChina
-
Essilor InternationalActive, not recruitingMyopia | Myopia, ProgressiveSingapore
-
Tianjin Eye HospitalCompleted
-
Aller, Thomas A., ODVisioneering Technologies, IncUnknownMyopia | Myopia, ProgressiveUnited States